
Can Fluid Biomarkers Predict MS Progression?
Could NfL and GFAP redefine how clinicians track progression in MS? Dr Mark Freedman joins Dr Anne Cross to explain the evolving science behind these powerful biomarkers. Relevant disclosures can be found with the episod









